Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Muehlhausen/thueringen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on triple-negative breast cancer and evaluating new combination therapies including immunotherapy agents. Research explores the effectiveness of combining atezolizumab with chemotherapy for improving patient outcomes.
These trials aim to advance treatment options for early-stage breast cancer patients.
Groundbreaking research investigating elacestrant for hormone-receptor-positive breast cancer, specifically targeting patients with ctDNA-positive ER+/HER2- early breast cancer.
Studies focus on delaying distant metastasis and improving survival outcomes.
Investigation of BRCA-mutated breast cancer treatments, including studies of olaparib as adjuvant therapy and innovative combinations with sacituzumab govitecan-hziy.
Research aims to improve outcomes for specific genetic and molecular subtypes of breast cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
